• Kyodo


The Supreme Court on Friday upheld high court rulings that the Japanese unit of British drugmaker AstraZeneca PLC bore no liability over fatal side effects caused by the lung cancer drug Iressa.

The top court thus turned down appeals from relatives of patients who died from side effects of the drug. It previously did not accept appeals against lower court rulings absolving the central government of liability over the deaths.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.